Spots Global Cancer Trial Database for Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma
Official Title: Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma
Study ID: NCT04225429
Conditions
Interventions
Study Description
Brief Summary: A multicenter, open-label expanded access program to provide access to tazemetostat to Epithelioid Sarcoma (ES) patients in serious need who are otherwise unable to participate in a clinical study or whom access is not available through marketed product in the US.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Ipsen Medical Director
Affiliation: Ipsen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
